| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 963 | 1,017 | 722 | 873 | 1,425 | 1,027 | 1,128 | 1,248 | 1,167 | 945 | 1,301 |
| Expenses | 856 | 877 | 621 | 701 | 1,041 | 763 | 847 | 905 | 845 | 616 | 869 |
| EBITDA | 107 | 140 | 101 | 173 | 384 | 264 | 281 | 343 | 322 | 329 | 431 |
| Operating Profit % | 9 % | 12 % | 11 % | 17 % | 23 % | 24 % | 24 % | 26 % | 27 % | 34 % | 32 % |
| Depreciation | 23 | 25 | 19 | 21 | 30 | 30 | 27 | 28 | 27 | 17 | 23 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 |
| Profit Before Tax | 83 | 115 | 99 | 158 | 355 | 233 | 253 | 314 | 273 | 312 | 408 |
| Tax | 30 | 36 | 38 | 56 | 101 | 57 | 61 | 85 | 72 | 77 | 103 |
| Net Profit | 54 | 79 | 61 | 102 | 254 | 177 | 193 | 230 | 201 | 234 | 307 |
| EPS in ₹ | 32.30 | 47.70 | 56.60 | 505.27 | 153.00 | 107.00 | 116.00 | 138.00 | 121.00 | 141.00 | 184.80 |
Procter & Gamble Health
Procter & Gamble Health
5,896.50
-50.50
(-0.85%)
Key Fundamentals
Market Cap
9,871.70 Cr
EPS
141.00
PE Ratio
31.90
Dividend Yield
2.12 %
Industry
Healthcare 52 Week High
6,739.00
52 Week Low
4,903.85
PB Ratio
15.79
Debt to Equity
0.01
Sector
Pharmaceuticals Actual
Company News
View All News
Procter & Gamble Health Limited announced its unaudited financial results for the quarter ended September 30, 2025. The company reported revenue from operations of ₹54.5 crores for the quarter, compared to ₹54.7 crores in the previous quarter and ₹51.1 crores in the corresponding quarter of the previous year. Net profit for the quarter stood at ₹88.6 crores, significantly higher than ₹66.2 crores in the previous quarter and ₹82.5 crores in the same quarter last year. For the six-month period ended September 30, 2025, revenue was ₹109.3 crores with net profit of ₹154.8 crores. The company's earnings per share for the quarter was ₹53.34. Cash and cash equivalents increased to ₹279.3 crores as of September 30, 2025, from ₹182.3 crores as of March 31, 2025. The Board of Directors approved these results at a meeting held on November 5, 2025.
Procter & Gamble Health Reports Higher Q2 Profit and Revenue Growth7 days ago
Procter & Gamble Health reported Q2 net profit of 885.4 million rupees compared to 823.3 million rupees in the same period last year. Revenue increased to 3.25 billion rupees from 3.13 billion rupees year-over-year. EBITDA rose to 1.2 billion rupees from 1.14 billion rupees, while EBITDA margin improved to 37.02% from 36.39% in the previous year.
Procter & Gamble Health Limited Completes Director Appointment Process for Shashank SrowthyOct 01, 2025
Procter & Gamble Health Limited announced that Mr. Shashank Srowthy has been allotted Director Identification Number (DIN) 11317956 by the Ministry of Corporate Affairs. Srowthy was appointed as Additional Director (Executive) effective October 1, 2025. The DIN was allotted through an order dated September 26, 2025, completing the appointment process that was initially announced on September 16, 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,732.10 | #1 4,11,749.90 | 39.63 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 66.26 | |
6,520.00 | 1,73,603.20 | 69.64 | 9,712.00 | 18.67 | 2,191 | 35.10 | 50.59 | |
3,824.60 | 1,29,482.50 | 60.46 | 11,539.40 | 6.99 | 1,911 | 30.46 | 70.50 | |
1,519.30 | 1,22,366.70 | 22.59 | 28,409.50 | 7.12 | 5,291 | 3.71 | 44.46 | |
1,229.60 | 1,01,113.50 | #1 17.88 | 33,741.20 | 16.73 | 5,725 | -0.38 | 47.35 | |
951.40 | 94,475.30 | 19.03 | 23,511.00 | 18.55 | 4,615 | 34.60 | 39.39 | |
2,270.00 | 91,653.00 | 52.89 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.59 | |
2,033.90 | 90,250.10 | 21.39 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 62.84 | |
5,767.50 | 68,110.20 | 29.54 | 13,458.30 | 3.70 | 2,216 | 21.39 | 70.49 | |
1,183.60 | 67,849.20 | 20.35 | 32,345.60 | 9.43 | 3,484 | 3.81 | 67.18 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-19.06 %
Net Income Growth
16.62 %
Cash Flow Change
-26.11 %
ROE
16.93 %
ROCE
13.19 %
EBITDA Margin (Avg.)
26.27 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 784 | 879 | 991 | 1,760 | 1,176 | 986 | 888 | 1,101 | 794 | 794 |
| Fixed Assets | 132 | 111 | 115 | 104 | 101 | 104 | 112 | 144 | 129 | 116 |
| Current Assets | 572 | 636 | 752 | 1,534 | 954 | 727 | 608 | 796 | 524 | 526 |
| Capital Work in Progress | 7 | 30 | 9 | 17 | 22 | 39 | 41 | 33 | 6 | 11 |
| Investments | 42 | 28 | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 603 | 711 | 797 | 1,639 | 1,053 | 843 | 736 | 925 | 660 | 667 |
| Total Liabilities | 784 | 879 | 991 | 1,760 | 1,176 | 986 | 888 | 1,101 | 794 | 794 |
| Current Liabilities | 165 | 186 | 225 | 193 | 227 | 239 | 232 | 304 | 219 | 215 |
| Non Current Liabilities | 27 | 29 | 33 | 27 | 42 | 44 | 40 | 46 | 37 | 42 |
| Total Equity | 592 | 664 | 733 | 1,540 | 906 | 704 | 617 | 751 | 538 | 537 |
| Reserve & Surplus | 575 | 647 | 717 | 1,524 | 890 | 687 | 600 | 734 | 522 | 520 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 4 | 17 | -16 | 1,109 | -483 | -172 | -145 | 116 | -197 | -57 |
| Investing Activities | -68 | -75 | -48 | 1,270 | 165 | -32 | -26 | -22 | -7 | 10 |
| Operating Activities | 84 | 107 | 54 | -130 | 235 | 247 | 170 | 236 | 228 | 169 |
| Financing Activities | -12 | -15 | -22 | -30 | -883 | -387 | -289 | -99 | -418 | -235 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % | 51.82 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 7.59 % | 6.24 % | 6.40 % | 6.61 % | 7.02 % | 6.87 % | 6.99 % | 7.24 % |
| DIIs | 11.48 % | 11.81 % | 8.37 % | 8.53 % | 7.90 % | 8.07 % | 12.62 % | 12.43 % | 12.31 % | 12.30 % | 12.13 % | 12.67 % | 13.73 % | 14.55 % | 14.84 % | 14.71 % | 14.21 % | 14.16 % | 13.91 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 24.58 % | 24.49 % | 24.80 % | 24.55 % | 24.81 % | 25.09 % | 24.46 % | 24.33 % | 24.09 % | 23.64 % | 23.43 % | 22.91 % | 22.61 % | 21.82 % | 21.46 % | 21.34 % | 21.90 % | 21.89 % | 22.15 % |
| Others | 12.13 % | 11.88 % | 15.01 % | 15.10 % | 15.47 % | 15.02 % | 11.11 % | 11.43 % | 11.78 % | 12.25 % | 12.62 % | 5.02 % | 5.60 % | 5.41 % | 5.28 % | 5.12 % | 5.21 % | 5.14 % | 4.89 % |
| No of Share Holders | 0 | 53,075 | 58,818 | 63,525 | 65,537 | 66,289 | 65,729 | 65,148 | 61,030 | 58,856 | 57,919 | 56,730 | 56,778 | 55,923 | 54,792 | 53,736 | 53,993 | 52,478 | 50,006 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 11 | 15 | 440 | 0.00 | 230 | 130 | 52.5 | 95 | 260 | 125 |
| Dividend Yield (%) | 1.05 | 1 | 11.91 | 0.00 | 3.71 | 3.25 | 1.12 | 2.02 | 5.05 | 2.1 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 06 May 2019 |  Change Of Name | NA | 06 May 2019 | 3,672.50 | 3,672.50 |
| 05 Nov 2021 |  Dividend | ₹ 40.00 /share | 02 Nov 2021 | 5,424.55 | 5,444.20 |
| 05 Nov 2021 | Dividend | ₹ 90.00 /share | 02 Nov 2021 | 5,374.30 | 5,444.20 |
| 13 May 2022 | Dividend | ₹ 41.00 /share | 12 May 2022 | 4,409.35 | 4,294.00 |
| 17 Nov 2022 | Dividend | ₹ 11.50 /share | 15 Nov 2022 | 4,190.70 | 4,290.60 |
| 23 Nov 2022 |  Annual General Meeting | NA | 23 Nov 2022 | 4,279.25 | 4,163.45 |
| 13 Feb 2023 | Dividend | ₹ 45.00 /share | 13 Feb 2023 | 4,096.95 | 4,702.90 |
| 24 Nov 2023 | Dividend | ₹ 50.00 /share | 23 Nov 2023 | 5,360.10 | 5,072.15 |
| 30 Nov 2023 | Annual General Meeting | NA | 30 Nov 2023 | 5,343.35 | 5,154.75 |
| 14 Feb 2024 | Dividend | ₹ 150.00 /share | 14 Feb 2024 | 5,136.60 | 5,503.95 |
| 14 Feb 2024 | Dividend | ₹ 50.00 /share | 14 Feb 2024 | 5,136.60 | 5,503.95 |
| 04 Nov 2024 |  Quarterly Result Announcement | NA | 04 Nov 2024 | 5,251.05 | 5,196.40 |
| 29 Nov 2024 | Dividend | ₹ 60.00 /share | 28 Nov 2024 | 5,422.90 | 5,168.55 |
| 05 Dec 2024 | Annual General Meeting | NA | 05 Dec 2024 | 5,373.45 | 5,346.85 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 5,446.35 | 5,259.70 |
| 21 Feb 2025 | Dividend | ₹ 80.00 /share | 21 Feb 2025 | 5,259.70 | 5,345.60 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 5,410.00 | 5,729.50 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 5,876.30 | 5,895.50 |
| 22 Aug 2025 | Dividend | ₹ 45.00 /share | 22 Aug 2025 | 5,729.50 | 6,338.50 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 6,185.55 | 6,298.50 |
| 05 Nov 2025 | Quarterly Result Announcement | NA | 05 Nov 2025 | 6,275.75 | 6,066.00 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release
7 days ago
7 days agoOutcome Of Board Meeting For The Quarter Ended September 30 20257 days ago
7 days agoBoard Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended September 30 20257 days ago
7 days agoRevision of Board MeetingOct 20, 2025
Oct 20, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 20, 2025
Oct 20, 2025Allotment Of DIN To Mr. Shashank Srowthy Executive DirectorOct 01, 2025
Oct 01, 2025Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 5 2025Sep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Sep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 08, 2025
Sep 08, 2025Change In Senior Management Personnel Of The CompanySep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Aug 29, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 29, 2025
Aug 29, 2025Intimation Regarding IEPFs 100 Days Campaign - Saksham NiveshakAug 26, 2025
Aug 26, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Approval Of Promoter Reclassification Pursuant To Companys Application Dated June 27 2018Aug 18, 2025
Aug 18, 2025Record Date For Annual General MeetingAug 06, 2025
Aug 06, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 06, 2025
Aug 06, 2025Annual Report For The Financial Year 2024-25 And Notice Calling The 58Th Annual General Meeting Of The CompanyAug 06, 2025
Aug 06, 2025Press Release For The Quarter Ended June 30 2025Aug 01, 2025
Aug 01, 2025Unaudited Financial Results For Quarter Ended June 30 2025Aug 01, 2025
Aug 01, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 01, 2025
Aug 01, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 27, 2025
Jun 27, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On August 1 2025Jun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 17, 2025
Jun 17, 2025Analysts/Institutional Investors - PresentationJun 16, 2025
Jun 16, 2025Change In Senior Management Personnel Of The Company
Jun 11, 2025
Jun 11, 2025Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health LimitedJun 09, 2025
Jun 09, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
May 29, 2025Appointment Of Secretarial AuditorsMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
May 29, 2025Corporate Action-Board approves DividendMay 29, 2025
May 29, 2025Financial Results For The Year Ended March 312025May 29, 2025
May 29, 2025Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
May 29, 2025Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
May 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Apr 14, 2025Appointment Of Mr. Sharad Tyagi (DIN- 00371842) And Ms. Krishna Sarma (DIN00016115) As Non-Executive Independent Directors Of The Company For A Period Of Five
YearsApr 10, 2025
Apr 10, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 10, 2025
Apr 10, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 29 2025Mar 26, 2025
Mar 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 10, 2025
Mar 10, 2025Integrated Filing (Financial)Feb 18, 2025
Feb 18, 2025Communication With Respect To Tds On Dividend Income Declared By The CompanyFeb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Feb 12, 2025Appointment Of Chairperson Of The BoardFeb 12, 2025
Feb 12, 2025Mutual Fund Holdings
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth 
UTI Healthcare Fund Direct-Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth 
Motilal Oswal Quant Fund Direct-Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
HDFC BSE 500 Index Fund Direct - Growth 
Bandhan Nifty Total Market Index Fund Direct-Growth 
Aditya Birla Sun Life MNC Fund Direct-Growth 
DSP Healthcare Fund Direct - Growth 
Nippon India Small Cap Fund Direct- Growth 
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct-Growth 
Sundaram Long Term Tax Advantage Fund Series IV Direct - Growth 
Tata India Pharma & Healthcare Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 38.28
ATR(14)
Less Volatile 144.01
STOCH(9,6)
Neutral 25.59
STOCH RSI(14)
Neutral 29.92
MACD(12,26)
Bearish -22.49
ADX(14)
Weak Trend 20.19
UO(9)
Bearish 46.87
ROC(12)
Downtrend And Accelerating -2.76
WillR(14)
Neutral -67.48
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
